莫西沙星治疗支原体肺炎的临床效果分析

Analysis of the Clinical Effect of Adult Patients with Mycoplasma Pneumonia by Moxifloxacin Treatment

目的探讨莫西沙星在支原体肺炎中的治疗价值。方法选取我院在2013年6月至2015年1月收治的102例支原体肺炎患者的临床资料,将患者随机分为两组,各51例,对照组给予红霉素治疗,观察组采用莫西沙星治疗,比较两组患者的治疗效果、退热时间、肺部阴影X线消失时间、止咳时间。结果 1观察组有50例患者治疗有效,总有效率为98.04%。对照组有41例患者治疗有效,总有效率为80.39%,比较有统计学意义(P<0.05)。2观察组的肺部阴影X线消失时间、止咳时间与退热时间均短于对照组,比较有统计学意义(P<0.05)。结论支原体肺炎患者通过给予莫西沙星治疗,临床治疗有效率明显提升,病情改善时间缩短,值得临床推广应用。

Objective To investigate the therapeutic value of moxifloxacin in mycoplasma pneumonia in.Methods In our hospital in January June 2013 to 2015,102 cases of mycoplasma pneumonia in patients with clinical data,the patients were randomly divided into two groups,51 cases.The control group received the treatment of erythromycin,the observation group with moxifloxacin in the treatment of,treatment effects were compared between the two groups,cooling time, shadow of lung X-ray disappeared,cough,time.Results In the observation group, 50 cases were efective and the total efective rate was 98.04%.In the control group,there were 41 cases of patients with efective treatment,the total effective rate was 80.39%,compared with statistical significance(P<0.05).II in the observation group shadows in the lungs by X-ray disap- pearance, cough,time and cooling time were shorter than that of the control group and had statistical significance (P<0.05). Conclusion Mycoplasma pneumonia patients by giving moxifloxacin treatment, clinical effective rate of the treatment improved significantly, his condition improved time is shortened, it is worthy of clinical application.